期刊文献+

胃食管反流病与幽门螺旋杆菌感染的相关性分析 被引量:3

下载PDF
导出
摘要 目的观察幽门螺杆菌(HP)感染与胃食管反流病(GERD)的相关性。方法经胃镜、24h食道pH监测、14C-尿素呼气试验、快速尿素酶试验、Warthin-starry染色检查,将50名Hp阳性不伴GERD的消化性溃疡(PU)患者分为2组,A组(治疗组;根除Hp组);B组(对照组;单纯抑酸治疗)。疗程结束后,观察Hp根除及GERD发生情况。结果治疗组幽门螺杆菌根除率为92%。疗程结束1个月后,治疗组中GERD发生率为8.7%,对照组GERD发生率为8.3%,2组间胃食管反流病发生率无显著差别。结论 PU患者根除HP后和GRED的发生无明显相关性。
出处 《中外医疗》 2010年第18期35-35,共1页 China & Foreign Medical Treatment
  • 相关文献

参考文献2

  • 1Rokkas T,Ladas SD,Triantafyllou K,et al.The association between cag Astatus and the development of esophagitis after the eradication of heli-cobacter pylori[J].Am J Med,2001,110(9):703 - 707.
  • 2Befrits R,Sjostedt S,Odman B,et al.Curing helicobacter pylori infectionin patients with duodenal ulcer does not provoke gastroe- sophageal refluxdisease[J].Helicobacter,2000,4(5):202 - 205.

同被引文献52

  • 1Irene Martinucci,Nicola de Bortoli,Maria Giacchino,Giorgia Bodini,Elisa Marabotto,Santino Marchi,Vincenzo Savarino,Edoardo Savarino.Esophageal motility abnormalities in gastroesophageal reflux disease[J].World Journal of Gastrointestinal Pharmacology and Therapeutics,2014,5(2):86-96. 被引量:22
  • 2Raghunath A, Hungin AP, Wooff D, et al. Prevalence of helicobacter pylori in patients with gastro-oesophageal reflux disease: systematic review[J]. BMJ, 2003, 326(7392): 737.
  • 3Nomura AM, Kolonel LN, Miki K, et al. Helicobacter pylori, pepsinogen, and gastric adenocarcinoma in Hawaii[J]. J Infect Dis, 2005, 191(12): 2075-81.
  • 4Fujiwara Y, Higuchi K, Watanabe Y, et al. Prevalence of gastroesophageal reflux disease and gastroesophageal reflux disease symptoms in Japan[J]. J Gastroenterol Hepatol, 2005, 20(1): 26-9.
  • 5Kim BC, Yoon YH, Jyung HS, et al. Clinical characteristics of gastroesophageal reflux diseases and association with Helicobacter pylori infection[J]. Korean J Gastroenterol, 2006, 47(5): 363-9.
  • 6Ashktorab H, Entezari O, Nouraie M, et al. Helicobacter pylori protection against reflux esophagitis[J]. Dig Dis Sci, 2012, 57(11): 2924-8.
  • 7Malfertheiner P, Dent J, Zeijlon L, et al. Impact of helicobacter pylori eradication on heartburn in patients with gastric or duodenal ulcer disease--results from a randomized trial programme [J]. Aliment Pharmacol Ther, 2002, 16(8): 1431-42.
  • 8Jadad AR, Moore RA, Carroll D, et al. Assessing the quality of reports of randomized clinical trials: is blinding necessary [J]? Control Clin Trials, 1996, 17(1): 1-12.
  • 9Befrits R, Sjostedt S, Odman B, et al. Curing helicobacter pylori infection in patients with duodenal ulcer does not provoke gastroesophageal reflux disease[J]. Helicobacter, 2000, 5(4): 202-5.
  • 10Jonaitis L, Kup6inskas J, Kiudelis G, et al. De novo erosive esophagitis in duodenal ulcer patients related to pre-existing reflux symptoms, smoking, and patient age, but not to Helicobacter pylori eradication: a one-year follow-up study[J]. Medicina (Kaunas), 2010, 46(7): 454-9.

引证文献3

二级引证文献23

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部